Cambridge Investment Research Advisors, Inc.
Position in NVS — Novartis AG
CIK 1419186
FAIRFIELD, IA
Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,288,951
+$917,793 QoQ
Shares Held
59,271
+8.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#180
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. NVS ranks #10 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
144,124 | $18,208,626 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,288,951 | 59,271 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $8,371,158 | 54,803 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $7,510,054 | 54,472 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,194,392 | 56,101 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,396,830 | 52,862 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $6,517,678 | 58,465 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $10,210,446 | 104,927 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,080,762 | 52,867 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $5,433,718 | 51,040 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $5,553,559 | 57,413 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $5,631,399 | 55,773 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,476,258 | 63,580 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $8,448,891 | 83,727 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $4,989,988 | 54,239 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,107,898 | 56,304 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,287,192 | 56,403 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,837,313 | 57,226 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $4,759,560 | 54,240 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,753,644 | 54,346 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $4,104,047 | 50,184 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $4,946,941 | 54,219 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,982,629 | 58,290 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,442,850 | 57,639 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $5,797,797 | 66,672 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $5,509,232 | 63,078 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $5,143,066 | 62,378 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||